1-6785593-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_015215.4(CAMTA1):c.45+18A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000349 in 888,544 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: not found (cov: 25)
Exomes 𝑓: 0.000035 ( 0 hom. )
Consequence
CAMTA1
NM_015215.4 intron
NM_015215.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.592
Publications
0 publications found
Genes affected
CAMTA1 (HGNC:18806): (calmodulin binding transcription activator 1) The protein encoded by this gene contains a CG1 DNA-binding domain, a transcription factor immunoglobulin domain, ankyrin repeats, and calmodulin-binding IQ motifs. The encoded protein is thought to be a transcription factor and may be a tumor suppressor. However, a translocation event is sometimes observed between this gene and the WWTR1 gene, with the resulting WWTR1-CAMTA1 oncoprotein leading to epithelioid hemangioendothelioma, a malignant vascular cancer. [provided by RefSeq, Mar 2017]
CAMTA1 Gene-Disease associations (from GenCC):
- cerebellar dysfunction with variable cognitive and behavioral abnormalitiesInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.5).
BP6
Variant 1-6785593-A-G is Benign according to our data. Variant chr1-6785593-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 1914392.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAdExome4 at 31 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 25
GnomAD3 genomes
Cov.:
25
GnomAD2 exomes AF: 0.0000939 AC: 3AN: 31946 AF XY: 0.0000554 show subpopulations
GnomAD2 exomes
AF:
AC:
3
AN:
31946
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000349 AC: 31AN: 888544Hom.: 0 Cov.: 30 AF XY: 0.0000263 AC XY: 11AN XY: 418142 show subpopulations
GnomAD4 exome
AF:
AC:
31
AN:
888544
Hom.:
Cov.:
30
AF XY:
AC XY:
11
AN XY:
418142
show subpopulations
African (AFR)
AF:
AC:
0
AN:
16594
American (AMR)
AF:
AC:
0
AN:
5050
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
7616
East Asian (EAS)
AF:
AC:
0
AN:
4422
South Asian (SAS)
AF:
AC:
0
AN:
24824
European-Finnish (FIN)
AF:
AC:
0
AN:
16936
Middle Eastern (MID)
AF:
AC:
0
AN:
1996
European-Non Finnish (NFE)
AF:
AC:
31
AN:
781846
Other (OTH)
AF:
AC:
0
AN:
29260
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome Cov.: 25
GnomAD4 genome
Cov.:
25
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Oct 08, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.